Quarterly report · Q2
2370.TEDINET S100QQH6
Period2022-10-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥349m | 2022-10-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥634m | 2021-10-01 → 2022-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥318m | 2021-10-01 → 2022-03-31 | Standalone | Net sales |
| Operating income | −¥672m | 2022-10-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥678m | 2021-10-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥670m | 2022-10-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.3bn | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥676m | 2021-10-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥674m | 2022-10-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥676m | 2021-10-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥677m | 2022-10-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥1.3bn | 2021-10-01 → 2022-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥679m | 2021-10-01 → 2022-03-31 | Standalone | Profit loss |
| Total assets | ¥5.4bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥6.1bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥6.3bn | at 2022-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥529m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥566m | at 2022-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥4.9bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.5bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.6bn | at 2022-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.0bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.5bn | at 2022-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥4.0bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2022-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2021-09-30d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥564m | 2022-10-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.2bn | 2021-10-01 → 2022-09-30 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥612m | 2021-10-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥35m | 2022-10-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥20m | 2021-10-01 → 2022-09-30 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2021-10-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥133m | 2022-10-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.6bn | 2021-10-01 → 2022-09-30 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥885m | 2021-10-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-3.19 | 2022-10-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.66 | 2023-01-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.33 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.63 | 2021-10-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.75 | 2022-01-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.7% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.3% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 213,465,757 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 211,730,423 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 197,000,423 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥313m |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥276,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥276,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥225m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥349m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥349m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥133m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥349m |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥349m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | −¥358m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥265m |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥69,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥69,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥308m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥318m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥318m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥105m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥318m |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥318m |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | −¥413m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 461
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 4344790000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 4033720000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 4499095000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration_NonConsolidatedMember | -1.75 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration_NonConsolidatedMember | -1.66 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 213465757 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 215041757 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 213465757 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 215041757 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 7655967 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.0358 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 2100000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0098 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 1400000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0065 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 1188200 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0055 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 1122400 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0052 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 1100000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0051 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 1016300 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0047 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 1013400 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0047 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 1005000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0047 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 1000000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0046 | |
| Number of shares held | CurrentQuarterInstant | 18601267 | |
| Shareholding ratio | CurrentQuarterInstant | 0.0871 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 213439900 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 2134399 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 25857 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 213465757 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 2134399 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | － | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | － | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | － | |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 4499095000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |